RECRUITING

Establishing Mobile Transcranial Magnetic Stimulation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.

Official Title

Portable Transcranial Magnetic Stimulation (TMS) in a Van for Treatment-Resistant Depression

Quick Facts

Study Start:2025-05-10
Study Completion:2028-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06748209

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:22 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adult (22-80 years old)
  2. * Have treatment-resistant depression as defined by the e-Mini, and the antidepressant treatment history form (ATHF short).
  3. * Be able to read and communicate in English.
  4. * Able to provide their own consent.
  5. * Access to a computer with videoconferencing ability for initial consent and telescreen.
  1. * Patients with unstable medical conditions that might make TMS unsafe. This includes current poorly controlled seizures.
  2. * Ferromagnetic metal in the head.
  3. * Pregnant.
  4. * Currently active substance abuse except tobacco.

Contacts and Locations

Study Contact

Mark S George, MD
CONTACT
8438765142
GEORGEM@MUSC.EDU
Alexandra Herron, BA
CONTACT
herronal@musc.edu

Principal Investigator

Mark George, MD
PRINCIPAL_INVESTIGATOR
Medical University of South Carolina

Study Locations (Sites)

Medical Univerity of South Carolina
Charleston, South Carolina, 29425
United States

Collaborators and Investigators

Sponsor: Medical University of South Carolina

  • Mark George, MD, PRINCIPAL_INVESTIGATOR, Medical University of South Carolina

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-10
Study Completion Date2028-03-01

Study Record Updates

Study Start Date2025-05-10
Study Completion Date2028-03-01

Terms related to this study

Keywords Provided by Researchers

  • Anxiety
  • Depression

Additional Relevant MeSH Terms

  • Treatment Resistant Major Depression